Lifecore Biomedical, Inc. LFCR Increase (Decrease) in Other Operating Assets
Increase (Decrease) in Other Operating Assets at other companies
Other financials
Where this comes from
Reported directly by Lifecore Biomedical, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOtherOperatingAssets.
The official record: Lifecore Biomedical, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Lifecore Biomedical, Inc.'s increase (decrease) in other operating assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Lifecore Biomedical, Inc.'s increase (decrease) in other operating assets?
- Lifecore Biomedical, Inc. (LFCR) reported increase (decrease) in other operating assets of -$209K in Q1 2026.
- How has Lifecore Biomedical, Inc.'s increase (decrease) in other operating assets changed year-over-year?
- Lifecore Biomedical, Inc.'s increase (decrease) in other operating assets increased by 87.1% year-over-year, from -$1.61M to -$209K.
- What is the long-term trend for Lifecore Biomedical, Inc.'s increase (decrease) in other operating assets?
- Over 3 years (2022 to 2025), Lifecore Biomedical, Inc.'s increase (decrease) in other operating assets has grown at a -18.1% compound annual growth rate (CAGR), from $689K to -$378K.
- What does increase (decrease) in other operating assets mean?
- This captures the net change in miscellaneous assets that are not classified as loans, securities, or property, plant, and equipment. It often includes items like accrued interest receivables, prepaid expenses, and other short-term operational assets.